Reglan: JPML Hearing held in Louisville, KY

A motion to form an MDL, or Multidistrict Litigation, was argued yesterday before the JPML sitting in Louisville, Kentucky. There are at least 15 Reglan lawsuits pending in 11 different district courts throughout the United States.

Reglan is prescribed to treat gastrointestinal disorders like diabetic gastroparesis, GERD (gastroesphageal reflux and delayed gastrict emptying.

Request for Reglan lawsuit consolidation was opposed by the attorneys for companies involved in the litigation, including Wyeth, who manufactured the brand name Reglan products, and several manufacturers of generic versions, such as Baxter, Pliva, Barr, Duramed, Actavis, Teva and Scwarz Pharma.

Reglan: FDA Video from YouTube

Interesting that the FDA now uploads video to youtube.com

Reglan: Generic Drug Makers and Metoclopramide

Reglan (metoclopramide) is prescribed for short-term treatment of gastrointestinal disorders.

Four generic drug makers named as Defendants in a Reglan lawsuit that is pending in a USDCT in Vermont won't be granted an immediate appellate appeal the Trial Court’s decision not to grant a pending motion for summary judgment. The argument was that the generic makers did not develop the drug’s warning label.

The lawsuit was filed against Wyeth, which manufactured the drug metoclopramide under the brand name Reglan, and others including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva.

You can read the opinion here, in PDF format. (D and B blog)





My office is investigating claims of injury related to Reglan, www.markzamora.com